Time course and cellular localization of inducible nitric oxide synthases expression during cardiac allograft rejection  Neil K Worrall, MD, Thomas P.

Slides:



Advertisements
Similar presentations
Volume 72, Issue 7, Pages (October 2007)
Advertisements

David D. Yuh, MD, Kimberly L. Gandy, MD, Bruce A
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
Robert S Poston, Margaret E Billingham, Jeffrey Pollard, E
Reduced hind limb ischemia-reperfusion injury in Toll-like receptor-4 mutant mice is associated with decreased neutrophil extracellular traps  Rahmi Oklu,
Experimental Bronchiolitis Obliterans Induced by In Vivo HVJ-Liposome–Mediated Endothelin-1 Gene Transfer  Shin-ichi Takeda, MD, Yoshiki Sawa, MD, Masato.
Volume 58, Issue 4, Pages (October 2000)
Wei Zhou, MD, Hong Chai, MD, PhD, Andy Courson, BS, Peter H
Gene Transfer Into the Donor Heart During Cold Preservation for Heart Transplantation  Satoshi Gojo, Kazuo Niwaya, Shigeki Taniguchi, Kazuhiko Nishizaki,
Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts  Gregory J. Fulton, MB, FRCSI,
Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine–induced injury in human internal thoracic.
Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury  Ren-Ke Li, MD, PhD, Donald A.G. Mickle,
The use of technetium tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection  Patrick W. Vriens, MDa, Francis G. Blankenberg,
Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts  Irvin Mayers, MD, Thomas Hurst, MVSc, Lakshmi.
Counterregulation of Interleukin-18 mRNA and Protein Expression During Cutaneous Wound Repair in Mice  Heiko Kämpfer, Heiko Mühl, Josef Pfeilschifter,
Liposome-mediated gene transfer to lung isografts
Gale Tang, MD, David N. Charo, Rong Wang, PhD, Israel F
Inhibitory Effects of Calcitonin Gene-Related Peptides on Experimental Vein Graft Disease  Xiaoning Zhang, MD, Jian Zhuang, MD, Hongsui Wu, MB, Zhihong.
Tracheal regeneration: Evidence of bone marrow mesenchymal stem cell involvement  Agathe Seguin, MD, PhD, Sonia Baccari, MD, Muriel Holder-Espinasse, MD,
Lipoplex gene transfer of inducible nitric oxide synthase inhibits the reactive intimal hyperplasia after expanded polytetrafluoroethylene bypass grafting 
Robert S Poston, Margaret E Billingham, Jeffrey Pollard, E
Gene transfer to coronary artery bypass conduits
Alexander S. Farivar, MD, Anton S. McCourtie, MRCS, Brendan C
A novel function for cadherin 11/osteoblast-cadherin in vascular smooth muscle cells: Modulation of cell migration and proliferation  Thomas S. Monahan,
The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia  Gale L. Tang,
Protective effects of cold spinoplegia with fasudil against ischemic spinal cord injury in rabbits  Hironori Baba, MD, Yoshihisa Tanoue, MD, PhD, Taketoshi.
Volume 61, Issue 5, Pages (May 2002)
Stem cell therapy in the aging hearts of Fisher 344 rats: Synergistic effects on myogenesis and angiogenesis  Jiang-Yong Min, MD, Yu Chen, MD, Sohail.
Thomas E. Arnold, MD, Dmitri Gnatenko, PhD, Wadie F. Bahou, MD 
Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury  Jian Zhang, MD, Jan Schmidt, MD,
Volume 114, Issue 3, Pages (March 1998)
Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes
Novel Bioresorbable Vascular Graft With Sponge-Type Scaffold as a Small-Diameter Arterial Graft  Tadahisa Sugiura, MD, PhD, Shuhei Tara, MD, PhD, Hidetaka.
In situ localization and quantification of seventy-two – kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta  William D. McMillan,
Daniel J. Wong, MD, Daniel Y. Lu, MD, Clinton D
William J. Dreyer, MDa, b, Sharon C. Phillips, BSa, Merry L
Overexpression of transforming growth factor–β1 correlates with increased synthesis of nitric oxide synthase in varicose veins  Theresa Jacob, PhD, Anil.
Volume 12, Issue 5, Pages (November 2005)
Expression and Function of Endothelial Nitric Oxide Synthase Messenger RNA and Protein Are Higher in Internal Mammary Than in Radial Arteries  Guo-Wei.
Fibronectin promotes VEGF-induced CD34+ cell differentiation into endothelial cells  Errol S Wijelath, PhD, Salman Rahman, PhD, Jacqueline Murray, PhD,
Coordinated Induction of Inducible Nitric Oxide Synthase and GTP-Cyclohydrolase I Is Dependent on Inflammatory Cytokines and Interferon-γ in HaCaT Keratinocytes:
Marrow Stromal Cells as Universal Donor Cells for Myocardial Regenerative Therapy: Their Unique Immune Tolerance  Rony Atoui, MD, MS, Juan-Francisco Asenjo,
Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits  Hiroshi Narita, MD, Sen Chen, PhD, Kimihiro Komori,
Transbronchial gene transfer of endothelial nitric oxide synthase to transplanted lungs  Anders Jeppsson, MD, Carlo Pellegrini, MD, Timothy O’Brien, MD,
Reduced Pulsatility Induces Periarteritis in Kidney: Role of the Local Renin–Angiotensin System  Chiyo Ootaki, MD, Michifumi Yamashita, MD, PhD, Yoshio.
Effects of Mycophenolate Mofetil on Cardiac Allograft Survival and Cardiac Allograft Vasculopathy in Miniature Swine  Margaret L. Schwarze, MD, Stuart.
Cyril Serrick, MSc, Adel Giaid, PhD, Alex Reis, MD, Hani Shennib, MD 
The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression  John R. Hoch, MD, Vida K. Stark,
Improvement of rejection-induced diastolic abnormalities in rat cardiac allografts with inducible nitric oxide synthase inhibition  Pablo F. Soto, MDa,
Periarteritis in Lung From a Continuous-Flow Right Ventricular Assist Device: Role of the Local Renin-Angiotensin System  Chiyo Ootaki, MD, Michifumi.
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
Hermann Aebert, MD, Torsten Cornelius, BS, Tobias Ehr, BS, Stephan R
Nitric oxide prevents p21 degradation with the ubiquitin-proteasome pathway in vascular smooth muscle cells  Melina R. Kibbe, MD, Suhua Nie, MD, Dai-Wu.
Volume 60, Issue 6, Pages (December 2001)
Apoptosis Is Involved in Acute Cardiac Allograft Rejection in Rats
Expression of Endothelin-1 and Constitutional Nitric Oxide Synthase Messenger RNA in Saphenous Vein Endothelial Cells Exposed to Arterial Flow Shear Stress 
Periostin Is a Novel Factor in Cardiac Remodeling After Experimental and Clinical Unloading of the Failing Heart  William E. Stansfield, MD, Nancy M.
Volume 63, Issue 2, Pages (February 2003)
Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs  Jiang-Yong.
A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1  Danny Chu, MD, Christopher C Sullivan, MS,
Volume 72, Issue 7, Pages (October 2007)
Volume 61, Issue 6, Pages (June 2002)
Immunosuppressive treatment of aortic allografts
Endobronchial transfection of naked TGF-β1 cDNA attenuates acute lung rejection  Franco D’Ovidio, MD, Motoki Yano, MD, Jon H Ritter, MD, Thalachallour.
Exogenous nitric oxide modulates the systemic inflammatory response and improves kidney function after risk-situation abdominal aortic surgery  Francisco.
β-chemokine function in experimental lung ischemia-reperfusion injury
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
Volume 61, Issue 3, Pages (March 2002)
Hideki Itano, MDa, Bassem N. Mora, MDa, Wanjiang Zhang, MDa, Jon H
Immunopathology of atopic dermatitis
Presentation transcript:

Time course and cellular localization of inducible nitric oxide synthases expression during cardiac allograft rejection  Neil K Worrall, MD, Thomas P Misko, PhD, Mitchell D Botney, MD, Patrick M Sullivan, MA, Jia-J Hui, MD, Gloria M Suau, MD, Pamela T Manning, PhD, T.Bruce Ferguson, MD  The Annals of Thoracic Surgery  Volume 67, Issue 3, Pages 716-722 (March 1999) DOI: 10.1016/S0003-4975(98)01346-0

Fig 1 Representative ribonuclease protection assay gel demonstrating inducible nitric oxide synthase (iNOS) mRNA expression in allograft hearts but not isograft or normal hearts. Grafted hearts were harvested on the indicated postoperative day and ribonuclease protection assay performed independently using rat iNOS and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; internal control) antisense probes. Lanes are as follows: 1, undigested probe; 2, probe hybridized with transfer RNA demonstrating that protection was specific for iNOS mRNA; 3, normal heart; 4 to 9, allograft hearts on postoperative days 3, 4, 5, 6, 8, and 10, respectively; 10 and 11, isograft hearts on days 5 and 8, respectively. The same results were obtained with duplicate samples in these animals and in two additional animals at each time point. The Annals of Thoracic Surgery 1999 67, 716-722DOI: (10.1016/S0003-4975(98)01346-0)

Fig 2 Inducible NOS (iNOS) enzyme activity present in allograft and isograft hearts harvested on the indicated postoperative day. Normal hearts produced 0.11 ± 0.11 pmol l-citrulline · mg protein−1 · min−1 (n = 7, P > 0.9 vs isografts and day 3 allograft). (Mean ± SEM; n = 4 to 8; ∗P < 0.0005 vs normal, isograft, and day 3 allograft; †P < 0.0005 vs normal and isograft and P = 0.002 vs day 3 allograft; and ‡P < 0.0005 vs normal, P = 0.002 vs isograft, and P = 0.02 vs day 3 allograft.) The Annals of Thoracic Surgery 1999 67, 716-722DOI: (10.1016/S0003-4975(98)01346-0)

Fig 3 Time course of increased in vivo nitric oxide production in allografts. Serum nitrite/nitrate levels were determined in allografts and isografts on the indicated postoperative day. Serum nitrite/nitrate levels in normals were 15 ± 1 μmol/L (n = 13, P > 0.2 vs isografts and day 3 allograft). (Mean ± SEM; n = 7 for isografts and n = 8 to 14 for allografts; ∗P = 0.0002 vs normal and isograft and P < 0.05 vs day 3 allograft; †P = 0.0002 vs normal, isograft, day 3 allograft, and P < 0.005 vs day 4 allograft; and ‡P = 0.0002 vs normal, P < 0.002 vs isograft and days 5 and 6 allograft, and P < 0.05 vs day 3 allograft.) The Annals of Thoracic Surgery 1999 67, 716-722DOI: (10.1016/S0003-4975(98)01346-0)

Fig 4 Representative darkfield and brightfield photomicrographs of in situ hybridization with rat iNOS antisense and sense mRNA probes demonstrating iNOS mRNA expression in infiltrating mononuclear inflammatory cells in allografts (oriented with the left ventricular cavity at top). (A) No iNOS expression in day 3 allograft. (B) iNOS expression in infiltrating mononuclear inflammatory cells in day 4 allograft but not in adjacent myocytes. (C) iNOS expression in interstitial space in day 6 allograft but not in myocytes. (D) iNOS expression in interstitial space in day 8 allograft. (E) No hybridization with the sense probe in the same day 8 allograft section. (F) iNOS mRNA was not detected in day 6 isografts. Similar results were obtained in 3 animals at each time. (Eosin; 100× except 1,000× for [B].) The Annals of Thoracic Surgery 1999 67, 716-722DOI: (10.1016/S0003-4975(98)01346-0)

Fig 5 Representative sections from allograft and isograft hearts stained with iNOS antisera. (A) Interstitial inflammatory cells expressed iNOS and appear to outline the myocytes, which did not stain for iNOS. (B) Perivascular infiltrating cells were positive for iNOS. iNOS was not present in endothelial cells or vascular smooth muscle cells. (C) Higher power demonstrating that iNOS-positive cells are mononuclear inflammatory cells. (D) There was no staining in the isograft heart, the normal heart (not shown), or with preimmune sera in any animal (not shown). Similar results were examined in 3 animals per group. (Mayer’s hematoxylin; 100× except 400× for [C].) The Annals of Thoracic Surgery 1999 67, 716-722DOI: (10.1016/S0003-4975(98)01346-0)